X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (326) 326
oncology (235) 235
chemotherapy (202) 202
male (201) 201
female (200) 200
adult (199) 199
brain neoplasms - drug therapy (189) 189
middle aged (175) 175
radiotherapy (159) 159
antineoplastic combined chemotherapy protocols - therapeutic use (158) 158
index medicus (153) 153
procarbazine (136) 136
vincristine (135) 135
vincristine - administration & dosage (134) 134
clinical neurology (131) 131
temozolomide (124) 124
gliomas (118) 118
aged (113) 113
procarbazine - administration & dosage (113) 113
lomustine - administration & dosage (107) 107
cancer (101) 101
treatment outcome (100) 100
brain neoplasms - pathology (90) 90
oligodendroglioma - drug therapy (86) 86
radiation-therapy (85) 85
combined modality therapy (84) 84
glioma - drug therapy (81) 81
medicine & public health (79) 79
vincristine chemotherapy (78) 78
brain neoplasms - radiotherapy (77) 77
lomustine (77) 77
oligodendroglioma (75) 75
survival (73) 73
dacarbazine - analogs & derivatives (71) 71
disease-free survival (69) 69
brain neoplasms - mortality (67) 67
prognosis (66) 66
tumors (66) 66
adolescent (62) 62
vincristine - therapeutic use (61) 61
brain neoplasms - therapy (60) 60
antineoplastic combined chemotherapy protocols - administration & dosage (59) 59
glioma (59) 59
retrospective studies (59) 59
astrocytoma - drug therapy (58) 58
survival analysis (56) 56
phase-ii (54) 54
anaplastic oligodendroglioma (53) 53
glioma - pathology (53) 53
antineoplastic combined chemotherapy protocols - adverse effects (52) 52
glioblastoma (51) 51
phase-iii trial (51) 51
brain neoplasms - genetics (50) 50
dacarbazine - therapeutic use (49) 49
malignant glioma (48) 48
procarbazine - therapeutic use (48) 48
antineoplastic agents - therapeutic use (47) 47
adjuvant chemotherapy (46) 46
care and treatment (46) 46
lomustine - therapeutic use (46) 46
phase-ii trial (45) 45
neoplasm recurrence, local - drug therapy (44) 44
astrocytoma (43) 43
neurology (43) 43
surgery (43) 43
chemotherapy, adjuvant (42) 42
disease progression (42) 42
pcv (41) 41
survival rate (41) 41
oligodendroglioma - pathology (40) 40
vincristine pcv (40) 40
antineoplastic agents, alkylating - therapeutic use (38) 38
brain tumors (37) 37
follow-up studies (37) 37
glioblastoma - drug therapy (37) 37
low-grade glioma (37) 37
oligodendroglioma - genetics (37) 37
glioblastoma-multiforme (36) 36
glioma - radiotherapy (35) 35
pcv chemotherapy (34) 34
glioma - therapy (33) 33
prognostic-factors (33) 33
astrocytoma - radiotherapy (32) 32
glioma - mortality (32) 32
young adult (32) 32
anaplastic astrocytoma (31) 31
neurosciences (31) 31
oligodendroglioma - radiotherapy (31) 31
randomized-trial (31) 31
magnetic resonance imaging (30) 30
brain-tumors (29) 29
ccnu (29) 29
european-organization (29) 29
radiation (29) 29
research (29) 29
adjuvant procarbazine (28) 28
brain cancer (28) 28
oligodendroglioma - therapy (28) 28
vincristine - adverse effects (28) 28
analysis (27) 27
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (391) 391
Japanese (4) 4
Czech (3) 3
French (3) 3
German (2) 2
Hungarian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Neuro-Oncology, ISSN 1522-8517, 11/2016, Volume 18, Issue 11, pp. 1529 - 1537
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2009, Volume 27, Issue 35, pp. 5881 - 5886
Purpose O6-methylguanine-methyltransferase (MGMT) promoter methylation has been shown to predict survival of patients with glioblastomas if temozolomide is... 
SURVIVAL | GLIOMAS | TRIAL | GLIOBLASTOMA | HYPERMETHYLATION | ONCOLOGY | LOMUSTINE PLUS TEMOZOLOMIDE | GENE-EXPRESSION | RADIOTHERAPY | O-6-METHYLGUANINE-DNA METHYLTRANSFERASE | CANCER | Procarbazine - administration & dosage | Astrocytoma - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Oligodendroglioma - genetics | Humans | Middle Aged | Brain Neoplasms - pathology | DNA Repair Enzymes - genetics | Gene Expression Regulation, Neoplastic | Oligodendroglioma - radiotherapy | Polymerase Chain Reaction - methods | Astrocytoma - pathology | DNA Methylation | Chromosomes, Human, Pair 1 | Time Factors | Tumor Suppressor Proteins - genetics | Astrocytoma - drug therapy | Vincristine - administration & dosage | Chemotherapy, Adjuvant | Brain Neoplasms - radiotherapy | Astrocytoma - mortality | Oligodendroglioma - drug therapy | Astrocytoma - genetics | Chromosome Deletion | Promoter Regions, Genetic | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Europe - epidemiology | Treatment Outcome | Brain Neoplasms - drug therapy | Disease-Free Survival | Chromosomes, Human, Pair 19 | DNA Modification Methylases - genetics | Oligodendroglioma - pathology | CpG Islands | Lomustine - administration & dosage | Original Reports | Neur8 | Neur1
Journal Article
Journal Article
Neurology, ISSN 0028-3878, 09/2004, Volume 63, Issue 5, pp. 904 - 906
Journal Article
Journal Article
REVISTA DE NEUROLOGIA, ISSN 0210-0010, 10/2018, Volume 67, Issue 8, pp. 293 - 297
Introduction. Radiotherapy with procarbazine, lomustine, and vincristine (PCV) improves overall survival in patients with anaplastic oligodendroglioma 1p19q... 
PCV | LOMUSTINE | 1p19q codeletion | TUMORS | CHEMOTHERAPY | CLINICAL NEUROLOGY | Oligodendroglioma | PHASE-III TRIAL | ADJUVANT PROCARBAZINE | ANAPLASTIC OLIGODENDROGLIOMA | LOW-GRADE GLIOMA | VINCRISTINE | Temozolomide | EUROPEAN-ORGANIZATION | INTERGROUP
Journal Article
Cancer, ISSN 0008-543X, 02/2004, Volume 100, Issue 4, pp. 807 - 813
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.